Digital health solutions are increasingly common in healthcare, with over
300,000 health apps available and more than half of U.S. adults using
digital health tools.

Where are the best digital spaces to find healthcare professionals (HCPs) in 2025? If you picture doctors, nurses and other HCPs buried in online medical journals, or engaging in discussions on specialized platforms like Doximity, you’re probably not wrong… But that’s only part of the story. The thing is that HCPs are just like the…

Unlock the Value of Effective Treatments: Discover how life sciences leaders can optimize patient outcomes and healthcare costs by addressing key questions about treatment adherence, healthcare utilization, and cost reduction.

If you’ve tuned into a podcast lately, chances are you’ve noticed that advertising formats have changed a little bit. Maybe you listened to the host give a heartfelt update about needing new revenue streams to keep the show going. Or maybe you noticed a few more ads than usual – some of which weren’t even…

Gram-negative bacteria. The very name can send shivers down the spines of healthcare professionals. These microorganisms, characterized by their complex cell wall structure, are increasingly developing resistance to even our strongest antibiotics.  If bacterial infections in general are a concern, gram-negative bacteria are particularly challenging – since even minor infections can become life-threatening when they…

Unlock unparalleled commercial success with PurpleLab®’s cutting-edge data analytics and real-world insights.

The healthcare landscape is more complex than ever – and pharmaceutical companies are feeling the pressure. From pre-commercial drug development to post-launch performance, success hinges on a deep understanding of the full patient journey. However, traditional approaches to patient mapping often miss the nuanced factors that shape real-world health outcomes. Enter real-world data (RWD) enriched…

Cancer survival rates have improved dramatically over the past few decades thanks to ongoing advances in therapeutics. As research continues to push the boundaries of medicine, two innovative technologies stand out in the fight against cancer: Antibody-Drug Conjugates (ADCs) and PROteolysis TArgeting Chimeras (PROTACs). These cutting-edge approaches are refining how we treat cancer and opening…

For all the buzz around the Inflation Reduction Act (IRA), opinions on its impact are sharply divided – especially in the life sciences sector. Critics argue that the IRA’s drug pricing provisions, particularly Medicare price negotiation, will stifle innovation by reducing incentives for pharmaceutical companies to invest in research and development.  But these concerns don’t…